Search Results - "Ryotaro, Tomida"

Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study by Miyake, Makito, Iida, Kota, Nishimura, Nobutaka, Miyamoto, Tatsuki, Fujimoto, Kiyohide, Tomida, Ryotaro, Matsumoto, Kazumasa, Numakura, Kazuyuki, Inokuchi, Junichi, Morizane, Shuichi, Yoneyama, Takahiro, Matsumura, Yoshiaki, Abe, Takashige, Inoue, Masaharu, Yamada, Takeshi, Terada, Naoki, Hirao, Shuya, Uemura, Motohide, Matsushita, Yuto, Taoka, Rikiya, Kobayashi, Takashi, Kojima, Takahiro, Matsui, Yoshiyuki, Kitamura, Hiroshi, Nishiyama, Hiroyuki

“…To explore possible solutions to overcome chronic Bacillus Calmette-Guérin (BCG) shortage affecting seriously the management of non-muscle invasive bladder…”
Get full text

Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy by Hashine, Katsuyoshi, Kakuda, Toshio, Iuchi, Shunsuke, Tomida, Ryotaro, Matsumura, Masafumi

“…To assess patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy. patient-reported…”
Get full text

PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer by Sakamoto, Shinichi, Sato, Kodai, Kimura, Takahiro, Matsui, Yoshiyuki, Shiraishi, Yusuke, Hashimoto, Kohei, Miyake, Hideaki, Narita, Shintaro, Miki, Jun, Matsumoto, Ryuji, Kato, Takuma, Saito, Toshihiro, Tomida, Ryotaro, Shiota, Masaki, Joraku, Akira, Terada, Naoki, Suekane, Shigetaka, Kaneko, Tomoyuki, Tatarano, Shuichi, Yoshio, Yuko, Yoshino, Takayuki, Nishiyama, Naotaka, Kawakami, Eiryo, Ichikawa, Tomohiko, Kitamura, Hiroshi

“…A multicenter study of nonmetastatic castration-resistant prostate cancer (nmCRPC) was conducted to identify the optimal cut-off value of prostate-specific…”
Get full text

Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias by Otsuka, Hikari, Kita, Yuki, Ito, Katsuhiro, Sano, Takeshi, Inokuchi, Junichi, Tomida, Ryotaro, Takahashi, Atsushi, Matsumoto, Kazumasa, Kurahashi, Ryoma, Ozaki, Yu, Uegaki, Masayuki, Maruyama, Satoru, Mukai, Shoichiro, Tsutsumi, Masakazu, Kawahara, Takashi, Segawa, Takehiko, Kitamura, Hiroshi, Morita, Satoshi, Kobayashi, Takashi

“…To investigate the association between the onset, severity, and type of immune‐related adverse events (irAEs) and the efficacy of pembrolizumab in patients…”
Get full text

Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients by Shiota, Masaki, Terada, Naoki, Saito, Toshihiro, Yokomizo, Akira, Kohei, Naoki, Goto, Takayuki, Kawamura, Sadafumi, Hashimoto, Yasuhiro, Takahashi, Atsushi, Kimura, Takahiro, Tabata, Ken‐ichi, Tomida, Ryotaro, Hashimoto, Kohei, Sakurai, Toshihiko, Shimazui, Toru, Sakamoto, Shinichi, Kamiyama, Manabu, Tanaka, Nobumichi, Mitsuzuka, Koji, Kato, Takuma, Narita, Shintaro, Yasumoto, Hiroaki, Teraoka, Shogo, Kato, Masashi, Osawa, Takahiro, Nagumo, Yoshiyuki, Matsumoto, Hiroaki, Enokida, Hideki, Sugiyama, Takayuki, Kuroiwa, Kentaro, Inoue, Takahiro, Mizowaki, Takashi, Kamoto, Toshiyuki, Kojima, Takahiro, Kitamura, Hiroshi, Sugimoto, Mikio, Nishiyama, Hiroyuki, Eto, Masatoshi

“…Metastatic burden is a critical factor for therapy decision‐making in metastatic hormone‐sensitive prostate cancer. The present study aimed to identify…”
Get full text

External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma by Hamamoto, Shuzo, Tasaki, Yoshihiko, Yamashita, Shimpei, Furukawa, Junya, Fujita, Kazutoshi, Tomida, Ryotaro, Miyake, Makito, Ito, Noriyuki, Iwamoto, Hideto, Sugiyama, Yosuke, Taguchi, Kazumi, Yasui, Takahiro

“…Pretreatment hemoglobin and neutrophil levels were previously reported to be important indicators for predicting the effectiveness of ipilimumab plus nivolumab…”
Get full text

Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data by Tomida, Ryotaro, Miyake, Makito, Minato, Ryoei, Sawada, Yuichiro, Matsumura, Masafumi, Iida, Kota, Hori, Shunta, Fukui, Shinji, Ohyama, Chikara, Miyake, Hideaki, Hongo, Fumiya, Taoka, Rikiya, Kobayashi, Takashi, Kojima, Takahiro, Matsui, Yoshiyuki, Nishiyama, Naotaka, Kitamura, Hiroshi, Nishiyama, Hiroyuki, Fujimoto, Kiyohide, Hashine, Katsuyoshi

“…Background This study investigated the clinical impact of carcinoma in situ (CIS) in intravesical Bacillus Calmette-Guérin (BCG) therapy for patients with…”
Get full text

Assistent guide: A novel device for ureteral stent placement in robot‐assisted intracorporeal ileal conduit by Sasaki, Yutaro, Takahashi, Masayuki, Fukuta, Kyotaro, Shiozaki, Keito, Daizumoto, Kei, Ueno, Yoshiteru, Tomida, Ryotaro, Tsuda, Megumi, Kusuhara, Yoshito, Fukawa, Tomoya, Yamaguchi, Kunihisa, Yamamoto, Yasuyo, Izaki, Hirofumi, Kanayama, Hiroomi

“…Introduction Ureteral stent placement in robot‐assisted intracorporeal ileal conduit formation (RICIC) is more challenging than extracorporeal urinary…”
Get full text

A propensity score matching study on robot-assisted radical cystectomy for older patients: comparison of intracorporeal ileal conduit and cutaneous ureterostomy by Kadoriku, Fumiya, Sasaki, Yutaro, Fukuta, Kyotaro, Atagi, Yuichiro, Shiozaki, Keito, Daizumoto, Kei, Tomida, Ryotaro, Ueno, Yoshiteru, Tsuda, Megumi, Kusuhara, Yoshito, Fukawa, Tomoya, Yanagihara, Yutaka, Yamaguchi, Kunihisa, Yamamoto, Yasuyo, Izaki, Hirofumi, Takahashi, Masayuki, Yamashi, Sadamu, Kan, Masaharu, Kanayama, Hiroomi

“…Robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion are less invasive than conventional procedures. However, for older patients,…”
Get full text

Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy by Nishimura, Nobutaka, Miyake, Makito, Iida, Kota, Miyamoto, Tatsuki, Tomida, Ryotaro, Numakura, Kazuyuki, Inokuchi, Junichi, Yoneyama, Takahiro, Matsumura, Yoshiaki, Yajima, Shugo, Masuda, Hitoshi, Terada, Naoki, Taoka, Rikiya, Kobayashi, Takashi, Kojima, Takahiro, Matsui, Yoshiyuki, Nishiyama, Naotaka, Kitamura, Hiroshi, Nishiyama, Hiroyuki, Fujimoto, Kiyohide

“…Objectives The US Food and Drug Administration recently defined the clinical term “bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer” as…”
Get full text

Impact of early urinary catheter removal on successful voiding and physical function in stroke patients by Tsuda, Megumi, Fukawa, Tomoya, Yamamoto, Yasuyo, Daizumoto, Kei, Sasaki, Yutaro, Ueno, Yoshiteru, Tomida, Ryotaro, Kusuhara, Yoshito, Yamaguchi, Kunihisa, Takahashi, Masayuki, Kanayama, Hiro-omi

“…Objective:The aim of the present study was to identify factors related to the success of trial without catheter (TWOC) in patients with stroke and to examine…”
Get full text

Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study by Tohi, Yoichiro, Kato, Takuma, Yokomizo, Akira, Mitsuzuka, Koji, Tomida, Ryotaro, Inokuchi, Junichi, Matsumoto, Ryuji, Saito, Toshihiro, Sasaki, Hiroshi, Inoue, Koji, Kinoshita, Hidefumi, Fukuhara, Hiroshi, Maruyama, Satoru, Sakamoto, Shinichi, Tanikawa, Toshiki, Egawa, Shin, Ichikura, Haruhiko, Abe, Takashige, Nakamura, Masaki, Kakehi, Yoshiyuki, Sugimoto, Mikio

“…•Lower MCS at AS enrollment leads in lower compliance with first repeat protocol biopsy.•How health-related quality of life of repeat protocol biopsy…”
Get full text

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort by Ito, Katsuhiro, Kobayashi, Takashi, Kojima, Takahiro, Hikami, Kensuke, Yamada, Takeshi, Ogawa, Kosuke, Nakamura, Kenji, Sassa, Naoto, Yokomizo, Akira, Abe, Takashige, Tsuchihashi, Kazunari, Tatarano, Shuichi, Inokuchi, Junichi, Tomida, Ryotaro, Fujiwara, Maki, Takahashi, Atsushi, Matsumoto, Kazumasa, Shimizu, Kosuke, Araki, Hiromasa, Kurahashi, Ryoma, Osaki, Yu, Tashiro, Yu, Uegaki, Masayuki, Ogawa, Osamu, Kitamura, Hiroshi, Nishiyama, Hiroyuki

“…Background The benefits of pembrolizumab in patients with advanced urothelial carcinoma (UC) and impaired performance status (PS) remain unknown. This study…”
Get full text

Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer by Terada, Naoki, Mizowaki, Takashi, Saito, Toshihiro, Yokomizo, Akira, Kohei, Naoki, Tabata, Ken‐ichi, Shiota, Masaki, Takahashi, Atsushi, Shimazui, Toru, Goto, Takayuki, Hashimoto, Yasuhiro, Fujii, Masato, Tomida, Ryotaro, Sakurai, Toshihiko, Hashimoto, Kohei, Kawamura, Sadafumi, Teraoka, Shogo, Sakamoto, Shinichi, Kimura, Takahiro, Kamiyama, Manabu, Narita, Shintaro, Tanaka, Nobumichi, Kato, Takuma, Kato, Masashi, Osawa, Takahiro, Kojima, Takahiro, Inoue, Takahiro, Sugimoto, Mikio, Nishiyama, Hiroyuki, Kamoto, Toshiyuki

“…Objectives To evaluate the association between the use of local radiotherapy (RT) with the survival of patients with de novo metastatic prostate cancer and…”
Get full text

Insulin receptor expression to predict resistance to axitinib and elucidation of the underlying molecular mechanism in metastatic renal cell carcinoma by Takahashi, Masayuki, Daizumoto, Kei, Fukawa, Tomoya, Fukuhara, Yayoi, Bando, Yoshimi, Kowada, Minoru, Dondoo, Tsogt-Ochir, Sasaki, Yutaro, Tomida, Ryotaro, Ueno, Yoshiteru, Tsuda, Megumi, Kusuhara, Yoshito, Yamaguchi, Kunihisa, Yamamoto, Yasuyo, Uehara, Hisanori, Kanayama, Hiroomi

“…Background The study aimed to examine the significance of insulin receptor (INSR) expression in predicting resistance to axitinib in clear cell renal cell…”
Get full text

Radical prostatectomy using the Hinotori robot‐assisted surgical system: Docking‐free design may contribute to reduction in postoperative pain by Sasaki, Yutaro, Kusuhara, Yoshito, Oyama, Takuro, Nishiyama, Mitsuki, Kobayashi, Saki, Daizumoto, Kei, Tomida, Ryotaro, Ueno, Yoshiteru, Fukawa, Tomoya, Yamaguchi, Kunihisa, Yamamoto, Yasuyo, Takahashi, Masayuki, Kanayama, Hiroomi, Furukawa, Junya

“…Background The docking‐free design of the Japanese Hinotori surgical robotic system allows the robotic arm to avoid trocar grasping, thereby minimising…”
Get full text

Cutaneous ureterostomy following robot-assisted radical cystectomy: a multicenter comparative study of transperitoneal versus retroperitoneal techniques by Sasaki, Yutaro, Yamamoto, Yasuyo, Fukuta, Kyotaro, Izumi, Kazuyoshi, Kadoriku, Fumiya, Daizumoto, Kei, Shiozaki, Keito, Tomida, Ryotaro, Kusuhara, Yoshito, Fukawa, Tomoya, Yanagihara, Yutaka, Yamaguchi, Kunihisa, Izaki, Hirofumi, Takahashi, Masayuki, Okamoto, Kenjiro, Yamanaka, Masahito, Furukawa, Junya

“…Background The aim of this study was to evaluate the differences in perioperative outcomes between transperitoneal and retroperitoneal techniques in cutaneous…”
Get full text

Robot-assisted partial nephrectomy in younger versus older adults with renal cell carcinoma: a propensity score-matched analysis by Tomida, Ryotaro, Fukawa, Tomoya, Kusuhara, Yoshito, Hashimoto, Keisuke, Shiozaki, Keito, Izumi, Kazuyoshi, Ninomiya, Iku, Kadoriku, Fumiya, Izaki, Hirofumi, Naroda, Takushi, Okamoto, Kenjiro, Kawanishi, Yasuo, Kanayama, Hiro-omi, Takahashi, Masayuki

“…Purpose Our study aimed to compare the surgical outcomes of robot-assisted partial nephrectomy (RAPN) between younger and older patients after adjusting for…”
Get full text

Primary resistance to nivolumab plus ipilimumab therapy affects second‐line treatment outcomes in patients with metastatic renal cell carcinoma by Mori, Kanami, Numakura, Kazuyuki, Matsushita, Yuto, Kojima, Takahiro, Osawa, Takahiro, Sazuka, Tomokazu, Hatakeyama, Shingo, Goto, Keisuke, Yamana, Kazutoshi, Kandori, Shuya, Kimura, Takahiro, Nishiyama, Naotaka, Bando, Yukari, Fujita, Kazutoshi, Ueda, Kosuke, Tanaka, Hajime, Tomida, Ryotaro, Kurahashi, Toshifumi, Kitamura, Hiroshi, Miyake, Hideaki, Habuchi, Tomonori

“…Nivolumab plus ipilimumab (NIVO+IPI) has a long‐term response rate of 30% for patients with metastatic renal cell carcinoma (mRCC). However, 20% of patients…”
Get full text

MO24-1 Comparison of Nivo-Ipi versus TKIs as first line therapy for mRCC: Real-world data from multicenter retrospective study by Miura, Noriyoshi, Mouri, Shinsuke, Maeda, Akihiro, Nishimura, Kenichi, Miyauchi, Yuki, Kikugawa, Tadahiko, Yuichiro, Sawada, Ryotaro, Tomida, Masafumi, Matsumura, Katsuyoshi, Hashine, Yutaka, Yanagihara, Iku, Ninomiya, Masaharu, Kan, Seiji, Asai, Takatoshi, Tacho, Takashi, Saika

Get full text